AB-CHMINACA |
cannabinoid |
39th ECDD (2017) - Critical review |
AB-FUBINACA |
cannabinoid |
42nd ECDD (2019) - Critical review |
AB-PINACA |
cannabinoid |
39th ECDD (2017) - Critical review |
Acecarbromal |
sedative |
24th ECDD (1988) - Critical review |
Acetorphine |
opioid |
15th ECDD (1966) - Critical review |
Acetyl-alpha-methylfentanyl |
opioid |
24th ECDD (1988) - Critical review |
Acetyldihydrocodeine |
opioid |
2nd ECDD (1950) - Critical review, 3rd ECDD (1952) - Critical review |
Acetylfentanyl |
opioid |
37th ECDD (2015) - Critical review |
Acetylmethadol |
opioid |
3rd ECDD (1952) - Critical review |
Acryloylfentanyl |
opioid |
39th ECDD (2017) - Critical review |
ADB-BUTINACA |
cannabinoid |
45th ECDD (2022) - Critical review |
ADB-CHMINACA |
cannabinoid |
41st ECDD (2018) - Critical review |
ADB-FUBINACA |
cannabinoid |
41st ECDD (2018) - Critical review |
Adinazolam |
benzodiazepine |
45th ECDD (2022) - Critical review |
AH-7921 |
opioid |
36th ECDD (2014) - Critical review |
Allobarbital |
sedative |
23rd ECDD (1987) - Critical review |
Allylprodine |
opioid |
10th ECDD (1960) - Critical review |
Alpha-acetylmethadol |
opioid |
4th ECDD (1954) - Critical review |
Alpha-methadol |
opioid |
4th ECDD (1954) - Critical review |
Alpha-methylfentanyl |
opioid |
24th ECDD (1988) - Critical review |
Alpha-methylthiofentanyl |
opioid |
26th ECDD (1989) - Critical review |
Alpha-methyltryptamine (AMT) |
stimulant |
36th ECDD (2014) - Critical review |
Alpha-PHP |
stimulant |
42nd ECDD (2019) - Critical review |
Alpha-PiHP |
stimulant |
45th ECDD (2022) - Critical review |
Alpha-Pyrrolidinovalerophenone |
stimulant |
37th ECDD (2015) - Critical review |
Alphameprodine |
opioid |
7th ECDD (1957) - Critical review |
AM-2201 |
cannabinoid |
36th ECDD (2014) - Critical review |
Amfepramone |
stimulant |
32nd ECDD (2001) – Pre-review, 33rd ECDD (2003) - Critical review |
Amineptine |
stimulant |
32nd ECDD (2001) – Pre-review, 33rd ECDD (2003) - Critical review |
Aminorex |
stimulant |
28th ECDD (1993) - Pre-review, 29th ECDD (1995) - Critical review |
Amphetamine |
stimulant |
17th ECDD (1970) - Critical review |
APINACA |
cannabinoid |
36th ECDD (2014) - Critical review, 42nd ECDD (2019) - Critical review |
Aprobarbital |
sedative |
23rd ECDD (1987) - Critical review |